|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$202,708,978 |
|
|
Indirect Value
|
$172,941,055 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$375,650,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 22 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-08 |
4 |
B |
$18.46 |
$923,000 |
I/I |
50,000 |
1,393,642 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-07 |
4 |
B |
$18.73 |
$936,500 |
I/I |
50,000 |
1,343,642 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-15 |
4 |
B |
$9.86 |
$941,551 |
I/I |
95,492 |
16,603,524 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2019-05-20 |
4 |
A |
$19.03 |
$951,500 |
I/I |
50,000 |
2,024,423 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2008-03-07 |
4 |
B |
$14.62 |
$964,920 |
I/I |
66,000 |
37,066 |
2.1 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-06-10 |
4 |
B |
$9.84 |
$984,000 |
I/I |
100,000 |
16,244,952 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-31 |
4 |
B |
$8.30 |
$996,000 |
I/I |
120,000 |
14,301,928 |
2.25 |
% |
|
YTEN |
Yield10 Bioscience Inc |
|
|
2023-05-05 |
4 |
B |
$2.98 |
$999,999 |
I/I |
335,570 |
962,956 |
0.01 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-23 |
4 |
B |
$5.89 |
$1,018,381 |
I/I |
172,900 |
13,551,928 |
2.25 |
% |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-24 |
4 |
A |
$6.92 |
$1,038,000 |
I/I |
150,000 |
13,701,928 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-24 |
4/A |
B |
$6.92 |
$1,038,000 |
I/I |
150,000 |
13,701,928 |
2.25 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2013-12-20 |
4 |
OE |
$9.93 |
$1,038,595 |
D/D |
76,867 |
3,391,920 |
0 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2013-12-20 |
4 |
D |
$27.54 |
$1,038,616 |
D/D |
(37,713) |
3,354,207 |
0 |
- |
|
BIOL |
Biolase Inc |
10% Owner |
|
2015-10-09 |
4 |
B |
$0.95 |
$1,045,000 |
I/I |
1,100,000 |
3,884,666 |
1.5 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-10-11 |
4 |
B |
$20.27 |
$1,045,932 |
I/I |
51,600 |
12,616,505 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-09-24 |
4 |
B |
$5.45 |
$1,047,490 |
I/I |
192,200 |
16,852,654 |
2.25 |
% |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2006-12-14 |
4 |
S |
$13.82 |
$1,053,213 |
D/D |
(75,446) |
2,720,425 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2016-06-09 |
4 |
B |
$14.17 |
$1,062,750 |
I/I |
75,000 |
736,994 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-08-21 |
4 |
B |
$21.34 |
$1,072,347 |
I/I |
50,000 |
12,564,905 |
2.25 |
- |
|
QDEL |
QuidelOrtho Corporation |
Director |
|
2011-08-08 |
4 |
B |
$14.00 |
$1,107,494 |
D/D |
79,135 |
3,247,288 |
2.39 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2016-06-29 |
4 |
B |
$13.94 |
$1,117,249 |
I/I |
80,147 |
12,182,305 |
2.25 |
- |
|
VMSI |
Ventana Medical Systems I... |
Director |
|
2008-02-11 |
4 |
D |
$89.50 |
$1,118,750 |
I/I |
(12,500) |
0 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2021-02-01 |
4 |
A |
$11.40 |
$1,140,000 |
I/I |
100,000 |
1,207,891 |
0 |
- |
|
ONCT |
Oncternal Therapeutics In... |
10% Owner |
|
2014-03-21 |
4 |
S |
$1.79 |
$1,143,164 |
D/D |
(638,639) |
6,165,261 |
0 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2020-03-25 |
4 |
B |
$7.70 |
$1,155,000 |
I/I |
150,000 |
13,851,928 |
2.25 |
% |
|
634 Records found
|
|
Page 22 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|